Article in BioStock: Follicum shows rapid progress with diabetes drug candidate
BioStock published an article about Follicum’s diabetes project on 7 January 2019 in Swedish . The article is here translated into English. Follicum is currently running its flagship drug candidate for hair loss, FOL-005, through Phase II clinical trials and the company has recently received key patent extension in the United States as well as an “intention to grant” in Europe. At the same time, the company’s new diabetes treatment project is rapidly advancing in preclinical development. A drug candidate will